Jiangsu Kanion Parmaceutical Co. Ltd;China Pharmaceutical University
发明人:
申请号：
EP15827281.5
公开号：
EP3175854A4
申请日:
2015.06.17
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Disclosed is a new use of a compound as indicated in structural formula I in preparing medications for preventing and/or treating pulmonary fibrosis. The compound having the structure as indicated in structural formula 1 substantially reduces the inflammation of diseased lung tissue, lowers the concentration of fibrosis factors TGF-²l in diseased lung tissue, decreases the excessive deposition of collagen in diseased lung tissue, and has substantial prevention and treatment effectiveness against fibrosis.
